NeoGenomics, a provider of cancer-focused genetic testing services and global oncology contract research services, agreed to acquire Intervention Insights (dba Trapelo Health), a clinical decision
![NeoGenomics to Acquire Clinical Decision Software Company Trapelo Health](https://mercomcapital.com/wp-content/uploads/2021/03/NeoGenomics-to-Acquire-Clinical-Decision-Software-Company-Trapelo-Health.png)
NeoGenomics, a provider of cancer-focused genetic testing services and global oncology contract research services, agreed to acquire Intervention Insights (dba Trapelo Health), a clinical decision